Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
We build accessible digital health solutions that leverage predictive algorithms and perform unique genomic studies in a bid to drive a person-centred, precision medicine approach to heart failure.
We seek to unravel the unique genome of every child with heart disease/failure in an effort to deliver precision and timely care, prevent complications, and improve outcomes. Learn more
Thank you to the 500 families who have participated in our program that investigates the genetic causes of heart failure in fetuses, children and adults. Learn more
Our Centre is driving a trio of advanced data-driven initiatives that are transforming heart failure research and personalized care now and into the future. Learn more
Through unique research efforts, innovations, and expert clinical care, we protect patients at risk or experiencing heart complications from cancer therapy. Learn more